Summary:
To evaluate the efficacy of NBI-1065846, used as adjunctive treatment to oral antidepressant medication(s), compared with placebo on improving symptoms of anhedonia in subjects with major depressive disorder (MDD).
Qualified Participants Must:
• Must be 18-65 years old at the time of consent
•
Diagnosed with MDD
•
Must be on stable treatment for depression
Qualified Participants May Receive:
Compesation up to $1,314
Complimentary transportation is avaialble for eligible participants.